Eritoran and apremilast in hospitalized patients with COVID-19: The REMAP-CAP immune modulation-2 domain

Authors:
  • FAFarah Al-Beidh
    Farah Al-Beidh
  • DADerek Angus
    Derek Angus
  • DADjillali Annane
    Djillali Annane
  • YAYaseen Arabi
    Yaseen Arabi
  • ABAbigail Beane
    Abigail Beane
  • LBLindsay Berry
    Lindsay Berry
  • SBScott Berry
    Scott Berry
  • ZBZahra Bhimani
    Zahra Bhimani
  • JBJanis Best-Lane
    Janis Best-Lane
  • MBMarc Bonten
    Marc Bonten
  • CBCharlotte Bradbury
    Charlotte Bradbury

Abstract
No abstract available
Funding Information
  • Translational Breast Cancer Research Consortium
  • University of Pittsburgh
  • Japan Science and Technology Agency
  • Eisai
  • Eisai Canada
  • Amgen